Application no. and date | 09793626.4 (espacenet) (Federated) (European Patent Register), 20091209 | Patent/reg. no. and date | DK/EP 2376500, 20150225 | Publication date | 20111019 | Priority no. and date | US 121676 P, 20081211 | EP pub. no. and date |
EP 2376500 20111019 | Effective date | | Applicant/owner | CTI BIOPHARMA CORP., 3101 Western Avenue, Suite 600
Seattle, WA 98121, US | Applicant ref. no. | P55876DK01 | Inventor | WILLIAM, Anthony, Deodaunia, 32 Woodlands Crescent 02-07 Northoaks
Singapore 738087, SG, LEE, Cheng Hsia, Angeline, Block 764 Jurong West St. 74 10-25
Singapore 640764, SG, DYMOCK, Brian, 20 Leonie Hill N° 16-20 Leonie Towers
Singapore 239222, SG | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 498/04 (2006.01) | Title | 11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENMALEATSALT | Int. application no. | SG2009000474 | Int. publication no. | WO2010068182 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|